Who we are
Who we are
INCiPiT is a non-profit Consortium, currently composed of 20 partners, including the main Italian pediatric hospitals and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), various Research Units dedicated to general hospitals, as well as some research organizations and international networks coordinated by Italian bodies.
Mission and Vision
We are a contact and coordination center for all national and international pediatric clinical trials involving Italian clinical sites, which are clinical excellences in the pediatric field.
We are committed to promoting the growth and quality of pediatric clinical trials in Italy. We give concrete support to the planning, conduct and completion of all types of pediatric clinical trials (profit and non-profit).
Objectives and Values
INCiPiT is a facilitator in the implementation of pediatric clinical trials, with the aim of promoting the exchange of knowledge between experts in the sector, offering specialized training opportunities and providing shared tools and guidelines to increase the quality and effectiveness of pediatric clinical research.
The Consortium makes the interconnection between its partners its greatest strength, thanks to the sharing of values such as cooperation, ethics and excellence.
Coordination Center Team
Francesca Rocchi
President
E francesca.rocchi@opbg.net
Pharmacist pharmacologist by training. Senior scientific manager with strong regulatory background in clinical research and Paediatric drug development, gained working for years in AIFA (Italian medicine Agency) and EMA (European medicine Agency). She is a member of the EMA PDCO (Paeditric committee) representing healthcare professionals.
Responsible for Regulatory Affairs at Bambino Gesù Children's Hospital - Clinical trials Area for the development of medicines, vaccines and devices for Paediatric use.
Elisabetta Bigagli
INCIPIT Pharmacovigilance Representative in c4c
E elisabetta.bigagli@unifi.it
Post-Doc researcher in pharmacology and toxicology at the University of Florence and INCiPiT referent for pharmacovigilance.
Lucia Di Maggio
Clinical Trial Specialist
E lucia.dimaggio@incipit-pediatric.net
Specialist in the Clinical Trials conduction and management. Her experience in profit and no profit research fuels her current duties that range from managing Start Up processes relevant to clinical budgets and coordinating activities of c4c EU-funded project.
Giulia Neccia
Communication Specialist
E giulia.neccia@opbg.net
Expert in Communications. Master in International Marketing and Management at St. Jospeph’s University Philadelpia – GEMA Business School
Silvia Fioravanti
Administrative Officier
E silvia.fioravanti@incipit-pediatric.net
Graduated in Biomedical Engineering.
Master's degree in Administration, Finance and Control
Sara Abbate
Clinical Project Manager
E sara.abbate@opbg.net
Pharmacist with Master's degree in Drug Development and Advanced Course in Clinical Research Methodology. Experience in conducting and managing pediatric clinical trials in the context of profit and non-profit research.
Clinical Trial Manager in the Clinical Studies Area for the Development and Implementation of Drugs, Vaccines and Medical Devices for pediatric use at the IRCCS Bambino Gesù Children's Hospital.
Anna Benedetta Del Signore
Clinical Project Manager
E anna.benedetta.delsignore@incipit-pediatric.net
Master's degree in Healthcare Management at the Catholic University of the Sacred Heart, Rome.
Management of profit and non-profit studies from the start-up phase to the end of study phase of approximately 5 years in both a hospital and pharmaceutical context;
Expertise in Health Economics and Outcomes Research and Real-World Evidence
Coordination of the activities of the European Project c4c-Conect4children .
Federica Sfrorza
Quality Assurance
E federica.sforza@opbg.net
Master in GXP Quality Systems and ISO.
Expert in developing and managing quality systems for conducting clinical trials at the highest level of compliance with current regulations. Always implementing continuous improvement in the quality of clinical trials in order to achieve reliable and accurate data and ensure the safety and well-being of study subjects.
